Temple Health Lung Center

Temple Lung Center Offers Innovative Treatments

The Temple Health Lung Center in Philadelphia is a national leader in the diagnosis and treatment of many conditions, ranging from common issues such as asthma to the most serious and complex health problems, including lung cancer and pleural mesothelioma.

It is part of the Temple University Health System, which also encompasses the Fox Chase Cancer Center, where many of its specialists also serve.

A national leader in the treatment of lung disease, Temple Health offers innovative options that include clinical trials and novel programs using cutting-edge technology.

Temple also treats interstitial lung disease, emphysema, sarcoidosis, acute respiratory distress syndrome and lower respiratory tract infections.

Temple Lung Center is spread across five different facilities, including the Temple University Hospital Main Campus on North Broad Street and the Jeanes Campus on Central Avenue, which was ranked among the top 5% of facilities in the U.S. in 2021.

Friedberg Leads Mesothelioma and Pleural Disease Program

Renowned thoracic surgeon Dr. Joseph Friedberg joined the team in 2022 as co-director of the Temple Health Mesothelioma and Pleural Disease Program. He also was named vice chair of surgical services for the Department of Thoracic Medicine and Surgery, and thoracic surgeon-in-chief of the Temple University Health System.

Friedberg served previously at the University of Maryland and the University of Pennsylvania. He is seeing patients at the Temple University Hospital Main Campus and at Fox Chase Cancer Center.

The lung cancer care team includes Dr. Hossein Borghaei, chief of medical oncology; radiation oncologist Dr. Sameera Kumar; and thoracic surgeon Dr. Prashant Shah. All are experienced in the treatment of mesothelioma.

Research Is Key at Temple Lung Center

Temple Lung Center has one of America’s most wide-ranging pulmonary research programs, which includes the study of respiratory failure, lung cancer, pulmonary fibrosis and arterial hypertension.

The center’s strong clinical research program involves dozens of ongoing clinical trials, leading to the development of new and more effective treatments.

Research is done as part of the Lewis Katz School of Medicine at Temple University. It often looks at the molecular and cellular causes of lung disease, translating those findings into more aggressive, personalized therapies.

Investigators stress a highly collaborative, multidisciplinary approach at Temple Lung Center, where they study immunology, physiology and pathology of many inflammatory lung diseases.